Open AccessCase Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation
Author(s) -
Ruiqiong Liu,
Wei Wei,
Huaying Hou,
Ping Cong,
Zhou Yong,
Xiaoming Yu
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s362185
Subject(s) - medicine , spinal cord , fibroblast growth factor receptor , targeted therapy , mutation , chemotherapy , cancer research , irinotecan , tyrosine kinase inhibitor , fibroblast growth factor receptor 1 , oncology , fibroblast growth factor , cancer , gene , colorectal cancer , biology , receptor , genetics , psychiatry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom